Atlas Trials

L-NMMA Plus Taxane Chemotherapy in Refractory Locally Advanced or Metastatic Triple Negative Breast Cancer Patients

Clinical trial NCT02834403 · COMPLETED

Trial details

NCT number
NCT02834403
Sponsor
The Methodist Hospital Research Institute
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Metastatic Triple Negative Breast Cancer
Start date
2016-11-01
Primary completion
2021-01-01
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.